Cargando…
Synergy between Human Peptide LL-37 and Polymyxin B against Planktonic and Biofilm Cells of Escherichia coli and Pseudomonas aeruginosa
The rise in antimicrobial resistant bacteria is limiting the number of effective treatments for bacterial infections. Escherichia coli and Pseudomonas aeruginosa are two of the pathogens with the highest prevalence of resistance, and with the greatest need for new antimicrobial agents. Combinations...
Autores principales: | Ridyard, Kylen E., Elsawy, Mariam, Mattrasingh, Destina, Klein, Darien, Strehmel, Janine, Beaulieu, Carole, Wong, Alex, Overhage, Joerg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952724/ https://www.ncbi.nlm.nih.gov/pubmed/36830299 http://dx.doi.org/10.3390/antibiotics12020389 |
Ejemplares similares
-
The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent
por: Ridyard, Kylen E., et al.
Publicado: (2021) -
Human Host Defense Peptide LL-37 Stimulates Virulence Factor Production and Adaptive Resistance in Pseudomonas aeruginosa
por: Strempel, Nikola, et al.
Publicado: (2013) -
In vitro synergy of antibiotic combinations against planktonic and biofilm Pseudomonas aeruginosa
por: Ghorbani, Hossein, et al.
Publicado: (2017) -
The secondary metabolite hydrogen cyanide protects Pseudomonas aeruginosa against sodium hypochlorite-induced oxidative stress
por: da Cruz Nizer, Waleska Stephanie, et al.
Publicado: (2023) -
Susceptibility of Pseudomonas aeruginosa Biofilm to Alpha-Helical Peptides: D-enantiomer of LL-37
por: Dean, Scott N., et al.
Publicado: (2011)